Home / Insights / Genome Editing Tools

insights-espresso-icon article

Genome Editing Tools

Espresso-live Speakers
by Meenakshi L
23 April 2015

Personalized medicine proposes customization of medication to individuals based on their genome (i.e. sum total of all the genes in their body). With the completion of human genome project the anticipation for personalized medicine and gene therapy rose. This can be analogous to locating a typographical error by a word processor and replacing the error with the correct letters, thereby ensuring correct meaning. Genome editing tools form the basis for personalized medicine, especially for therapies requiring change in genome. Currently there are four contenders to this - Meganucleases, ZNF Nucleases, TALENs and CRISPRs. Although, the technologies are many, there are very few commercial providers of this technology. This is attributed to the fact that select few possess the intellectual property rights of turning these technologies to valid form of therapy; for example, ZFN patent with Sangamo BioSciences and TALENs with Cellectis, Transposagen and Life Technologies.

Linkedin Twitter Facebook
Leave a comment

Please enter a valid name

Post your comment

Please select captcha


Get more stories like this

Subscirbe for more news,updates and insights from Beroe

Get Ahead with AI-Enabled Market Insights Schedule a Demo Now

Schedule a Demo Now